血小板因子4通过抑制整合素α5-FAK-ERK通路诱导骨质损失
Wei Li1,2, Qiwei Zhang3,4, Ranli Gu5
1Department of Oral Pathology, Peking University School and Hospital of Stomatology, National Center for Stomatology, National Clinical Research Center for Oral Diseases, National Engineering Research Center of Oral Biomaterials and Digital Medical Devices, Beijing Key Laboratory of Digital Stomatology, National Health Commission Key Laboratory of Digital Technology of Stomatology, Peking University, Beijing, China.
血小板因子4 (PF4) 损害了骨髓中酶干细胞 (BMMSC) 的分化和骨形成. 这项研究表明,PF4通过抑制ITGA5-FAK-ERK通路而加剧骨质疏松症,从而导致骨质损失.
科学领域:
- 干细胞生物学 干细胞生物学
- 骨生物学 骨生物学 骨生物学
- 分子生物学分子生物学
背景情况:
- 血小板因子4 (PF4) 在骨髓介质干细胞 (BMMSC) 和骨质疏松症中的作用尚不清楚.
- 了解PF4的影响对于开发骨质疏松症治疗至关重要.
研究的目的:
- 在骨质疏松症模型中研究PF4对BMMSC和骨损伤的影响.
- 为了阐明PF4诱导的骨损失的潜在分子机制.
主要方法:
- 在体外评估BMMSC增殖,细胞循环和骨质分化.
- 建立一个由卵巢切除 (OVX) 诱导的骨质疏松性小鼠模型.
- 分析骨微观结构,PF4水平,基因表达和蛋白质通路.
主要成果:
- 在实验室中,PF4降低了BMMSC的扩散和骨质分化.
- 在体内,OVX导致PF4水平升高,骨微型结构恶化.
- 在小鼠中,PF4补充剂加剧了骨质恶化,并抑制了ITGA5-FAK-ERK通路.
结论:
- 通过抑制骨形成,PF4有助于OVX诱导的骨损失.
- 通过ITGA5-FAK-ERK通路,PF4抑制了BMMSC的骨质分化.
- 针对ITGA5-FAK-ERK通路可能为骨质疏松症提供治疗策略.
相关概念视频
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Intracellular Signaling Affects Focal Adhesions
Some...
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Clot Retraction and Fibrinolysis
Osteoclasts in Bone Remodeling
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...


